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Previewsauthors also investigated the previously
identified E3 ligases RBCK1 and Ro52
and their involvement in the IRF3 ubiquiti-
nation. Their results demonstrated that
these E3 ligases play a role in negative
regulation of IRF3, but RAUL is the prin-
cipal E3 ligase involved in degradation of
IRF3 and IRF7 (Yu and Hayward, 2010).
The authors broadened their study of
RAUL by revealing a role for viral RTA in
the evasion of the host immune response.
It is this link with KHSV pathogenesis that
further distinguishes this study (Yu and
Hayward, 2010). They demonstrated
that RTA can hijack cellular RAUL and
modulate the stability of RAUL by recruit-
ing the deubiquitinating enzyme HAUSP.
Silencing HAUSP led to an increase in
RAUL stability by preventing self-ubiquiti-
nation and proteolysis. By taking control
of HAUSP, RTA enhanced RAUL activity,
leading to greater IRF3 and IRF7 protea-
somal degradation. Considering that RTA
itself possesses E3 ligase activity capable
of targeting IRF3 and IRF7 for degradation(Yu et al., 2005), the question arises as to
why KSHV goes through the trouble of
hijacking RAUL and recruiting HAUSP,
instead of simply using RTA to promote
IRF3 and IRF7 degradation? The question
may be more complex, considering that
IRF3 is essential for induction of host
restriction factors within the context of
an ongoing IFN response. Redundantly
targeting both IRF3 and IRF7 for degrada-
tion may be a safeguard in the context of
virus replication and immune evasion.
These anti-IRF countermeasures may
also serve as a switch between cycles of
lytic and latent KSHV infection. Perhaps
the RTA-HAUSP-RAUL complex also
assists KSHV to downregulate its viral
IRF-like proteins that are induced during
viral reactivation and thus favors a shift
toward latent infection. Beyond the scope
of the authors’ contributions to the under-
standing of RAUL biology and IRF degra-
dation, these findings are likely to provide
insights into the pathogenesis of KSHV-
associated disease.Immunity 33, DREFERENCES
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In this issue of Immunity, Kerdiles et al. (2010) report that Foxo transcription factors are essential for the
development and function of Foxp3-expressing regulatory T (Treg) cells via controlling the expression of
genes associated with Treg cell function.Foxo transcription factors belong to the
Forkhead box family of transcription
factors characterized by a conserved
winged helix DNA binding domain. In
mammals, the Foxo subfamily is com-
prised of four members, Foxo1, Foxo3,
Foxo4, and Foxo6. Foxo1 and Foxo3 are
the main isoforms expressed in the
immune system. They are important
regulators of cell cycle progression, apo-
ptosis, glucose metabolism, and stress
resistance via integrating information of
the presence of nutrients, growth factors,
and stress signals. Recent studies haveshown that Foxo transcription factors are
also associated with lymphocyte func-
tions such as gene recombination,
homing, and cytokine receptor expres-
sion. Although Foxo transcription factors
appear to play important roles in a variety
of biological processes, the functions of
Foxo1 and Foxo3 in T cells still remain
obscure. In this issue of Immunity, Ker-
diles et al. (2010) investigate autoimmunity
resulting from T cell-specific deletion of
Foxo1 and additional deletion of Foxo3.
They conclude that Foxo transcription
factors are essential for specifying theprogram of T cell differentiation especially
into regulatory T (Treg) cells expressing
the transcription factor Foxp3 (Figure 1).
Foxo transcription factors can act as
either transcriptional activators or repres-
sors by forming different molecular com-
plexes with different transcriptional
modulators including b-catenin, STAT3,
Runx3, Smad3, or Smad4. In addition,
their function is tightly regulated by the
upstream phosphoinositide 3-kinase
(PI3K) and Akt pathway, which phosphor-
ylates Foxo molecules and facilitates their
nuclear export into the cytoplasm. Afterecember 22, 2010 ª2010 Elsevier Inc. 835
Figure 1. Foxo1 and Foxo3 Are Necessary
for the Development and Function
of Regulatory T cells
The PI3K-Akt pathway is an upstream signal for the
Foxo family members. It induces phosphorylation
of Foxo transcriptional factors and their nuclear
export into the cytoplasm. Foxo1 and Foxo3 bind
to the promoter regions of Foxp3 and CTLA-4
and other genes. Those factors are required for
the adequate gene expression of Foxp3 and its
target genes, such as CTLA-4, in Treg cells.
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Previewsantigen or cytokine stimulation, Foxo
transcription factors are rapidly phos-
phorylated and deactivated in a PI3K-
dependent manner, whereas cytokine
withdrawal elicits their dephosphorylation
and activation. Foxo transcription factors
are therefore the major downstream
target of the PI3K-Akt signaling pathway.
In immune cells, the PI3K pathway is acti-
vated by several stimuli via specific
receptors, including the B cell antigen
receptor (BCR), T cell antigen receptor
(TCR), and cytokine and chemokine
receptors. Thus Foxos may well play an
essential part in immune cell functions.836 Immunity 33, December 22, 2010 ª2010Kerdiles et al. (2010) made mice with
a T cell-specific deletion of Foxo1 by
crossing Cd4-cre mice with Foxo1f/f
mice. They found that mice with a T cell-
specific deletion of Foxo1 harbor an
expanded population of activated and/or
memory CD4+CD44hi T cells and devel-
oped B cell autoimmunity as evidenced
by B cell activation, hypergammaglobuli-
nemia, and the production of autoanti-
bodies. Youngmice with conditional dele-
tion of Foxo1 in CD4+ T cells exhibited
a noticeable decrease in the proportion
and the number of Foxp3+ Treg cells
among thymic mature CD4 single-posi-
tive cells, whereas Foxo1-deficient
Foxp3+ Treg cells expanded in the periph-
eral lymphoid organs. However, such
Foxp3+ Treg cells were nonfunctional
in vivo, suggesting that the autoimmunity
associated with Foxo1 deficiency in
CD4+ T cells could be attributed to im-
paired function of Foxp3+ Treg cells.
Notably, whereas the Foxp3 expression
was nearly normal in Foxo1-deficent
Treg cells, their expression of Treg-
associated genes, such as CD25 and
CTLA-4, were substantially reduced.
Indeed, by chromatin immunoprecipita-
tion, Foxo1 was shown to bind to the
upstream of the transcription initiation
site of the Ctla4 gene, and the Foxo
binding element was required for full
expression of CTLA-4. Recently, Ouyang
et al. (2010) also reported that mice with
T cell-specific deletion of both Foxo1
and Foxo3 developed fatal systemic
inflammatory disease due in part to func-
tional defect in Foxp3+ Treg cells. They
showed that Foxo1 and Foxo3 directly
bind to the Foxp3 promoter region and
transactivate its promoter activity in a
Foxo1 binding sequence specificmanner.
Thus, these reports together indicate that
Foxo family transcription factors are
required for appropriate control of the
expression of Foxp3 and its target genes
and that impairment in this Foxo-depen-
dent gene expression in Foxp3+ Treg cells
hampers their function and thereby
produces autoimmunity.
One feature of the Foxo family tran-
scription factors is that they have func-
tional redundancy between their iso-
forms. Dejean et al. (2009) and Hosaka
et al. (2004) reported that Foxo3-deficient
mice showed no significant immunolog-
ical abnormalities, such as spontaneous
autoimmunity. Foxo3 deficiency did notElsevier Inc.alter the number or the proportion of
activated or effector-memory T cells in
the spleen and the lymph nodes. More-
over, T cells purified from Foxo3/ mice
showed no defect in proliferation and
survival after in vitro stimulation. These
results suggest that a loss of Foxo3 alone
is not sufficient to elicit manifestations of
T cell activation or autoimmunity. How-
ever, double-deficient mice produced
by crossing Cd4-Cre Foxo1f/f mice with
Foxo3-deficient mice developed severe
systemic autoimmunity accompanying
splenomegaly and lymphadenopathy
(Kerdiles et al., 2010). Furthermore, reten-
tion of only one allele of either Foxo1 or
Foxo3 in T cells was sufficient to prevent
any major defects in Treg cell differentia-
tion, contrasting with a marked reduction
of thymic Treg cells in Foxo1/Foxo3/
mice to approximately 50% of wild-type
mice (Ouyang et al., 2010). These findings
collectively indicate a redundancy in the
function of Foxo1 and Foxo3 for the
control of thymic Treg cell development
and consequently for T cell homeostasis.
Transforming growth factor-b (TGF-b),
which has pleiotropic effects, depending
on cell types, induces Foxp3 expression
in antigen-stimulated naive T cells. The
phenotype of TGF-b-deficient or TGF-b
receptor I-deficient mice closely resem-
bles that of Foxp3-deficient mice; all
these mutant strains develop lethal auto-
immunity by 3–4 weeks of age. Kerdiles
et al. (2010) showed that induction of
TGF-b-induced Treg (iTreg) cells was
highly impaired when T cells from tamox-
ifen-treated ER-Cre Foxo1f/f mice were
stimulated by TGF-b, suggesting that
Foxo1 is necessary for Foxp3 induction
in iTreg cell differentiation. Moreover,
TCR stimulation elicited an increase in
the expression of T-bet, a key transcrip-
tion factor for Th1 cell differentiation, in
both wild-type and Foxo1-deficient
T cells, whereas addition of TGF-b dimin-
ished T-bet expression in wild-type but
not Foxo1-deficient T cells. These data
indicate that Foxo1 is required for
TGF-b-induced Treg cell differentiation,
at least in part, via downregulation of
T-bet. Harada et al. (2010) also showed
that TGF-b-induced Foxp3 expression
was impaired in CD4+ T cells from
Cbl-b-deficient mice. Cbl-b-deficient
T cells displayed augmented Foxo3 phos-
phorylation; further, forced expression of
Foxo3 rescued their TGF-b-dependent
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PreviewsFoxp3 expression. A Foxo3 binding motif
is present in a proximal region of the
Foxp3 promoter and was shown to be
required for Foxp3 expression. Collec-
tively, these studies have revealed that
Foxo transcription factors promote the
transcription of the Foxp3 gene in iTregs
(Kerdiles et al., 2010; Harada et al.,
2010; Ouyang et al. 2010).
Regulation of Foxo transcriptional
activity is mainly dependent on the phos-
phorylation of the Foxo proteins via PI3K-
Akt pathway. Binding of growth factors to
their receptors initiates PI3K and Akt acti-
vation, followed by Foxo phosphorylation,
leading to inactivation of Foxos. The
mammalian target of rapamycin (mTOR)
is also one of the downstream targets of
Akt. Recent studies (Haxhinasto et al.,
2008; Sauer et al., 2008) have docu-
mented that mTOR forms the PI3K-Akt-
mTOR axis in regulating Foxp3 expres-
sion. The involvement of mTOR in the
differentiation of iTreg cells was further
supported by the finding that T cells lack-
ing mTOR kinase differentiate into iTreg
cells by TCR stimulation alone in the
absence of TGF-b. It is therefore plausible
that PI3K-Akt signaling might suppress
the Foxp3 expression via mTOR activa-
tion and Foxos inactivation.Collectively, the studies by Kerdiles
et al. and others strongly support the
notion that Foxo1 and Foxo3 have critical
overlapping roles in the development of
thymic-derived natural Treg and TGF-b-
induced iTreg cells. Kerdiles et al. (2009)
previously reported that Foxo1 regulates
the homeostasis and life span of naive
T cells. Yet it remains unclear how Foxos
play different roles when they are in naive
or Treg cells. Furthermore, several inter-
acting partners with Foxos have been
identified, whereas the mechanisms by
which Foxos regulate their target genes
in Treg cells still remain unknown. Recent
studies have shown that a functional
NFAT binding site lies in the Foxp3
enhancer region, with close proximity to
the Smad3 binding motif (Tone et al.,
2008), and the Runx transcription factors
are critically involved in induction and
suppressive function of Treg cells through
the direct binding to the Foxp3 gene
(Kitoh et al., 2009). Taken together, Treg
development via Foxp3 induction is a
complex event controlled by a variety of
transcription factors, including Foxo
family transcription factors. Further study
is required to decipher the complex tran-
scriptional network for regulating Foxp3
expression.Immunity 33, DREFERENCES
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Foxp3+ regulatory T cells can manifest functional ‘‘reprogramming’’ during inflammation. In this issue of
Immunity, Sharma et al. (2010) show how reprogramming is beneficial to CD8+ T cell immunity and how
the tumor microenvironment inhibits this process.Regulatory T (Treg) cells are key media-
tors in the control of immune responses
toward self- and non-self-antigens, and
suppression of excessive immune re-
sponses that can cause pathology in
the host (Wing and Sakaguchi, 2010; Pic-
cirillo et al., 2008). Treg cells develop as
a functionally specialized T cell subset inthe thymus and specifically express the
transcription factor Foxp3, a master
switch in Treg cell development (Hori
et al., 2003; Fontenot et al., 2005). Sus-
tained Foxp3 expression is required for
the genetic programming of Treg cell phe-
notype and suppressive function (Hori
et al., 2003; Fontenot et al., 2005; d’Hen-nezel et al., 2009). A developmental or
functional deficiency in Foxp3-expressing
Treg cells in mice and humans breaks
tolerance to self- and non-self -antigens
and provokes a spectrum of T cell-medi-
ated outcomes including multiorgan
autoimmunity, immunity to tumors and
microbes, and chronic inflammatoryecember 22, 2010 ª2010 Elsevier Inc. 837
